| Approved to make real-time, color images of men's prostate glands, ProUroCare will next pilot the clinical technology in select medical centers MINNEAPOLIS, May 1, 2012 /PRNewswire/ -- ProUroCare Medical Inc. (OCTBB: PUMD), provider of proprietary medical imaging products, announced today it has received clearance from the U.S. Food & Drug Administration (FDA) for its ProUroScan™ prostate mechanical imaging (PMI) system. The approval paves the way for men and their families ...continued PUMD prostatectomy bph Healthcare |
Tuesday, May 1, 2012
ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment